These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25258407)

  • 41. Serum gastrin levels during long-term omeprazole treatment.
    Koop H; Klein M; Arnold R
    Aliment Pharmacol Ther; 1990 Apr; 4(2):131-8. PubMed ID: 2104080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
    Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
    Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
    Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
    Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
    Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
    Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
    Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A
    World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
    Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
    Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.
    Merli M; Lucidi C; Di Gregorio V; Giannelli V; Giusto M; Ceccarelli G; Riggio O; Venditti M
    Liver Int; 2015 Feb; 35(2):362-9. PubMed ID: 24836902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum and urinary metabolomics and outcomes in cirrhosis.
    Bajaj JS; Fan S; Thacker LR; Fagan A; Gavis E; White MB; Heuman DM; Fuchs M; Fiehn O
    PLoS One; 2019; 14(9):e0223061. PubMed ID: 31560724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis.
    Bajaj JS; Reddy KR; Tandon P; Garcia-Tsao G; Kamath PS; O'Leary JG; Wong F; Lai J; Vargas H; Thuluvath PJ; Subramanian RM; Pena-Rodriguez M; Sikaroodi M; Thacker LR; Gillevet PM
    Liver Transpl; 2022 Dec; 28(12):1831-1840. PubMed ID: 36017804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota: its role in hepatic encephalopathy.
    Rai R; Saraswat VA; Dhiman RK
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
    Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis.
    Dultz G; Piiper A; Zeuzem S; Kronenberger B; Waidmann O
    Aliment Pharmacol Ther; 2015 Mar; 41(5):459-66. PubMed ID: 25523381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
    Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
    Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
    Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
    Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.